- Clinical Trials
- April 2025
- 90 Pages
Global
From €2158EUR$2,500USD£1,870GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1726EUR$2,000USD£1,496GBP
- Report
- December 2025
- 391 Pages
Global
From €4143EUR$4,799USD£3,589GBP
- Report
- March 2025
- 1048 Pages
Global
From €4143EUR$4,799USD£3,589GBP
- Report
- February 2025
- 138 Pages
Global
From €2000EUR$2,482USD£1,793GBP
- Report
- March 2025
- 1000 Pages
Global
From €2188EUR$2,535USD£1,896GBP
€3367EUR$3,900USD£2,917GBP
- Report
- January 2026
- 270 Pages
Global
From €1571EUR$1,820USD£1,361GBP
€2417EUR$2,800USD£2,094GBP
- Report
- November 2025
- 160 Pages
Global
From €1571EUR$1,820USD£1,361GBP
€2417EUR$2,800USD£2,094GBP
- Report
- November 2025
- 231 Pages
Global
From €4014EUR$4,650USD£3,478GBP
- Report
- May 2025
- 200 Pages
Global
From €2149EUR$2,490USD£1,862GBP
- Report
- January 2026
- 187 Pages
Global
From €3400EUR$3,939USD£2,946GBP
- Report
- January 2026
- 192 Pages
Global
From €3400EUR$3,939USD£2,946GBP
- Report
- January 2026
- 184 Pages
Global
From €3400EUR$3,939USD£2,946GBP
- Report
- January 2026
- 185 Pages
Global
From €3400EUR$3,939USD£2,946GBP
- Report
- January 2026
- 191 Pages
Global
From €3400EUR$3,939USD£2,946GBP
- Report
- January 2026
- 197 Pages
Global
From €3400EUR$3,939USD£2,946GBP
- Report
- January 2026
- 181 Pages
Global
From €3400EUR$3,939USD£2,946GBP
- Report
- January 2026
- 188 Pages
Global
From €3400EUR$3,939USD£2,946GBP
- Report
- January 2026
- 193 Pages
Global
From €3400EUR$3,939USD£2,946GBP
- Report
- January 2026
- 197 Pages
Global
From €3400EUR$3,939USD£2,946GBP

Programmed Cell Death Protein (PDP) is a type of protein that plays a role in the regulation of cell death in the body. It is a key component of the body's natural defense against cancer, as it helps to prevent the growth and spread of cancerous cells. In oncology drugs, PDP is used to target and destroy cancer cells, while leaving healthy cells unharmed. PDP is also used to reduce the side effects of chemotherapy and radiation therapy, as well as to reduce the risk of recurrence of cancer. PDP is also used to reduce the risk of metastasis, or the spread of cancer to other parts of the body.
PDP is a rapidly growing market, with many companies developing and marketing PDP-based drugs. Some of these companies include Merck, Bristol-Myers Squibb, AstraZeneca, Novartis, and Pfizer. Show Less Read more